SEC Company Response from Forbes Medi-Tech Inc. (CIK 0001087477) — Sep 15, 2005
Forbes Medi-Tech Inc. (CIK 0001087477)
Date: Sept. 15, 2005 · CIK: 0001087477 · Accession: 0001176256-05-000329
AI Filing Summary & Sentiment
File numbers found in text: 000-30076
Letter
United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 USA
Dear Mr. Rosenberg;
Re:
Forbes Medi-Tech Inc. (the “Company”)
Form 40-F for the year ended December 31, 2004
Your File Reference 000-30076
Further to your correspondence dated August 23, 2005, please be advised that, unfortunately, we will be unable to reply to your inquires as set out in your said August 23rd correspondence by today’s date. Therefore, by way of this correspondence, we would appreciate you granting an extension of time to Monday, September 19, 2005.
Thank you for your attention in this matter. Should you require any additional information, please do not hesitate to contact the undersigned at (604) 689-5899.
Yours truly,
FORBES MEDI-TECH INC.
“David Goold”
David Goold, CA
Chief Financial Officer
cc:
Audit Committee, Forbes Medi-Tech Inc.
Mr. Nitin Kaushal, Director
cc:
Mr. Charles Butt, Forbes Medi-Tech Inc.
President and CEO
cc:
Legal Counsel
Ms. Nancy Glaister, Cawkell Brodie Glaister
Show Raw Text
CORRESP 1 filename1.htm August 4, 2004 September 15, 2005 Filed via EDGAR Mr. Jim Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 USA Dear Mr. Rosenberg; Re: Forbes Medi-Tech Inc. (the “Company”) Form 40-F for the year ended December 31, 2004 Your File Reference 000-30076 Further to your correspondence dated August 23, 2005, please be advised that, unfortunately, we will be unable to reply to your inquires as set out in your said August 23rd correspondence by today’s date. Therefore, by way of this correspondence, we would appreciate you granting an extension of time to Monday, September 19, 2005. Thank you for your attention in this matter. Should you require any additional information, please do not hesitate to contact the undersigned at (604) 689-5899. Yours truly, FORBES MEDI-TECH INC. “David Goold” David Goold, CA Chief Financial Officer cc: Audit Committee, Forbes Medi-Tech Inc. Mr. Nitin Kaushal, Director cc: Mr. Charles Butt, Forbes Medi-Tech Inc. President and CEO cc: Legal Counsel Ms. Nancy Glaister, Cawkell Brodie Glaister